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Ending the Message Minireview
Is Not So Simple
Nicholas Proudfoot splicing. Instead it can effectively be considered a regu-
lator of the poly(A) signal. The associated U1SnRNPmaySir William Dunn School of Pathology
Chemical Pathology Unit in this context act as a poly(A) factor rather than splicing
factor. Furthermore U1SnRNP hasbeen shown to cross-University of Oxford
South Parks Road link with poly(A) signals and may have a key function in
defining the last exon of mRNAs through its dual splicingOxford OX1 3RE
England and polyadenylation functions (Wassarman and Steitz,
1993).
Figure 2 summarizes the various examples of such
regulated poly(A) sites. The Calcitonin, Bovine PapillomaIntroduction
Virus (BPV), and HIV-1 examples each employ spliceThe plethora of mechanisms associated with the regula-
donor sites to regulate the adjacent poly(A) site (posi-tion of gene expression in eukaryotes is a remarkable
tively in the case of Calcitonin and negatively for BPVfeature of biology. The generally held view that promoter
and HIV). However, in all three cases the donor site canselection is the predominant regulatory mechanism is
regulate polyadenylation even though it is not necessar-increasingly challenged by the discovery of ever ex-
ily involved in splicing. Thus for HIV-1, the major splicepanding numbers of alternately processed mRNAs, that
donor site inhibits the 59 LTR poly(A) signals even at latein turn generate an enormous range of protein products.
stages of viral infection when at least half of the viralHowever generating alternative proteins by selecting
transcripts are unspliced (Ashe et al., 1995).The BPV latedifferent poly(A) sites has remained a disappointingly
poly(A) site is inhibited by a sequence that resembles arare phenomenon (at least for people working on
donor site and appears to interact with U1SnRNP evenpoly(A)). That polyadenylation might afford a useful site
though this sequence is not known to act as a spliceto regulate gene expression is in part implied by the
signal (Furth et al., 1994). Finally the Calcitonin poly(A)extraordinary complexity of this process (Wahle and
site is regulated by a 39 positioned, so called intronicKeller, 1996, for recent review).
enhancer that looks uncannily like a splice acceptorPolyadenylation Is Surprisingly Complex
fused to a donor site without any intervening exon se-One might naively assume that only two proteins are
quences. The binding of U1SnRNP as well as the pyrimi-required for polyadenylation, a specific endonuclease
dine tract binding protein and splicing factor SF2/ASFto cleave the pre-mRNA and poly(A) polymerase to add
have all been implicated by in vitro experiments in acti-the poly(A) tail. However as shown in Figure 1, a whole
vation of the upstream poly(A) site (Lou et al., 1996). Thebattery of proteins including the 3-4 subunit Cleavage
ability of U1A protein, targeted to positions close to thePoly(A) Specificity Factor (CPSF) and 3 subunit Cleavage
SV40 late and U1A poly(A) signals to regulate polyadeny-Stimulatory Factor (CstF) together with two multisubunit
lation may well be an extension of using the wholeCleavage Factor proteins (CFI and CFII) are needed to
U1SnRNP complex as with Calcitonin, BPV, and HIV-1.recognize a poly(A) signal and cleave the RNA. Although
only asingle polypeptide,Poly(A)Polymerase (PAP) adds
poly(A) to the newly formed 39 end, this activity requires
RNA bound CPSF and yet another polypeptide called
Poly(A) Binding ProteinII (PABII) to help make the full
z200n poly(A) tail. Recent evidence provides a direct
role for poly(A) in both translation initiation and RNA
turnover. Another protein PABI bound to the poly(A) tail
in the cytoplasm recruits the 40s ribosomal subunit to
the mRNA, so promoting translation initiation, and also
stimulates mRNA decapping, thereby enhancing mRNA
degradation. This emphasizes the importance of poly(A)
in gene expression (Tarun and Sachs, 1995; Caponigro
and Parker, 1995). Possibly the addition of poly(A) to an
mRNA is so critical to getting gene expression right
that it has in general proved too dangerous to use this
process for regulation. Even so there are a few well Figure 1. Multiple Proteins MediateSpecific Cleavage and Polyade-
documented cases of gene regulation at this level and nylation of mRNA 39 Ends
it is the purpose of this minireview to discuss these The detailed biochemistry of polyadenylation has been reviewed
cases. most recently by Wahle and Keller (1996). The pre-mRNA is shown
as a grey line with the indentation indicating the site of cleavagePoly(A) Sites “Talk” to Splice Donor Sites
(scissors). The extending poly(A) tail is also included on the diagramMost clear examples of poly(A) site regulation described
with multiple PABII binding. Well defined molecular interactions in-to date appear to rely on the relative strength of the
clude the 160kD CPSF subunit with AAUAAA and the 64kD CstFregulated poly(A) signal. Furthermore this is often modu-
subunit with GU/U (denoted by parallel lines). Also PAP interacts
lated by interactions with adjacent splice donor sites or with CPSF by contacting the 160kD subunit and CPSF interacts
their associated factors. Surprisingly in several cases with CstF by contacts between the 160kD and 77KD subunits. (This
diagram was kindly drawn by Tom Furlong).the regulating donor site may not actually function in
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while the secreted form is expressed in later develop-
mental stage plasma cells. This regulatory process has
intrigued molecular biologists for at least a decade and
has prompted a range of exploratory efforts to crack its
secret. First off the 59 positioned secreted form poly(A)
signal is weak, as it lacks an extensive GU/U rich region,
required for efficient CstF binding. It is also positioned
within an intron, so that it must compete with an up-
stream donor site. In contrast the 39 positioned mem-
brane form poly(A) site is stronger having a pronounced
GU rich sequence to allow more efficient CstF binding.
Increasing the strength of the secreted form poly(A) site
causes secreted antibody to be made at all develop-
mental stages. In contrast mutation of the 59 donor site
to a stronger splice signal causes membrane bound
antibody to be expressed at all developmental stages
(Peterson and Perry, 1989). It is apparent that the rela-
tively weak donor and secreted poly(A) sites are exqui-
sitely balanced to ensure correct regulation of these
two competing RNA processing mechanisms. Indeed
replacing the IgM donor and secreted poly(A) site with
completely heterologous signals still allows correct reg-
ulation, provided they are of balanced strength (Pe-
terson, 1994). The question is which does the regulation,
splicing or polyadenylation?
This question is now very directly addressed in a pa-
per combining the expertise of the Manley and Peterson
laboratories (Takagaki et al., 1996, this issue). Most
previous studies on this regulatory process have relied
on tumor cell lines derived from B cells and plasma
cells. However, in this new report, primary B cells were
Figure 2. Regulated Poly(A) Site Selection induced to differentiate and it is shown that one of the
Top panel shows 39 terminal alternate exons (colored boxes) and in- subunits in CstF, the 64kD polypeptide dramatically in-
trons (lines) of the Calcitonin and IgM genes. Splicing patterns and creases in concentration (over 10 fold) immediately sug-
poly(A) signals are indicated, as are activating (1) and inhibiting (-) gesting a connection with the switch in poly(A) site use.
effects of splice signals or changes in CstF concentration (see text).
To directly test this idea a chicken B cell line was em-Middle panel shows diagrams of three regulated mRNA 39ends. For
ployed as it has the useful property of transfecting withBPV late, U1A SnRNP interacting with the splice donor element (SD)
very high efficiency. Following the cloning and charac-inhibitspolyadenylation. For SV40 late, 3 upstream sequence elements
(USE) of the poly(A) site may bind U1A protein as part of U1SnRNP terization of the chicken 64kD protein, it was transfected
and so enhance polyadenylation by interaction with CPSF. For U1A into the cell line so that clones were obtained that ex-
mRNA, upstream sequences ofthis poly(A) signal provide binding sites pressed either low or very high levels of 64kD protein.
for U1A protein which in turn inhibit polyadenylation thus creating an
Low and behold a switch in expression of the endoge-auto regulatory loop.
nous chicken IgM heavy chain gene from membrane toBottom panel shows diagrams of two viruses. For HIV-1, the LTRs
secreted form is observed when the 64kD protein isare blue boxesseparated by a line denotingthe rest of the viralgenome,
not drawn to scale. For Adenovirus, the whole virus is depicted as a overexpressed, pretty well matching the developmental
blue box. As indicated, the major splice donor site of HIV-1 inhibits switch in heavy chain expression during development.
polyadenylation of59LTR transcripts whereasthe alternate poly(A) sites This study goes on to confirm that more 64kD correlates
of Adenovirus are regulated by decreasing the level of polyadenylation
with more CstF and furthermore the membrane poly(A)activity during viral infection.
site really does bind CstF with higher affinity than the(This diagram was kindly drawn by Tom Furlong).
secreted form poly(A) site. So it would appear that the
case is proven for regulation of IgM heavy chains by
Again this regulatory effect can be either positive or regulating the amount of CstF during B cell develop-
negative. Thus U1A apparently activates SV40 late poly- ment. That is at early developmental stages the limiting
adenylation by interaction with CPSF (Lutz et al., 1996) concentration of CstF favors the stronger 39 positioned
and inhibits U1A mRNA polyadenylation by interaction poly(A) signal, while at later stages the weaker secreted
with PAP (Gunderson et al., 1994). poly(A) site gets a look in, because CstF is now ex-
Membrane Bound or Secreted Antibody Heavy pressed at higher levels. Of course an interesting ques-
Chains Generated by Alternative Polyadenylation tion that remains to be answered is what causes the
The first clear example of poly(A) site regulation associ- alteration in expression levels of the 64kD protein during
ated with the production of alternative protein products B cell development.
is the case of the secreted and membrane bound vari- As is often the case in biological research, other stud-
ants of antibody heavy chains (see Figure 2). The mem- ies on this phenomenon come up with rather different
views. One study on this same regulatory process usingbrane form is expressed in early developmental B cells,
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Lou, H., Gagel, R.F., and Berget, S.M. (1996). Genes and Devel. 10,in vitro polyadenylation extracts derived from either B
208–219.cell or plasma cell lines concluded that there was more
Lutz, C.S., Murthy, K.G.K., Schek, N., O’Connor, J.P., Manley, J.L.,general polyadenylation activity in late stage plasma cell
and Alwine, J.C. (1996). Genes and Devel. 10, 325–337.extracts than in B cell extracts but that the actual amount
Mann, K.P., Weiss E.A., and Nevins, J.R. (1993). Mol. Cell. Biol. 13,of 64kD protein does not vary (Edwalds-Gilbert and Mil-
2411–2419.
carek, 1995). A second related study came up with an
Peterson, M.L. (1994). Mol. Cell. Biol. 14, 7891–7898.activity derived from B cell extracts that appears to
Peterson, M.L., and Perry, R.P. (1989). Mol. Cell. Biol. 9, 726–738.specifically destabilize interactions of CstF with the se-
Takagaki, Y., Seipelt, R.L., Peterson, M.L., and Manley, J.L. (1996).creted poly(A) signal (Yan et al., 1995). These two studies
Cell 87, this issue.
suggest that other mechanisms exist as well as increas-
Tarun, S.Z., and Sachs, A.B. (1995). Genes and Devel. 9, 2997–3007.ing 64kD expression to enhance polyadenylation during
Wahle, E., and Keller, W. (1996). TIBS 21, 247–251.development and so switch heavy chain expression.
Wassarman, K.M., and Steitz, J.A. (1993). Genes and Devel. 7,Possibly tumor cell lines have lost the basic mechanism
647–659.
to up regulate 64kD expression but retain the other ill-
Yan, D.-H., Weiss, E.A., and Nevins J.R. (1995). Mol. Cell. Biol. 15,defined polyadenylation enhancing or destabilising ac-
1901–1906.
tivities. It is in any case surprising that this switch in
heavy chain expression should solely rely on up regula-
tion of a ubiquitous poly(A) factor, as it would be pre-
dicted that other genes might have their pattern of ex-
pression affected by such a mechanism. One other case
of poly(A) site regulation should be mentioned in this
context. Adenovirus has multiple poly(A) signals and in
particular the L1 and L3 poly(A) sites are differentially
expressed during early and late stages of viral infection
(L1 early and L3 late—Figure 2). Like antibody heavy
chain genes these two poly(A) sites have different
strengths so that L3 binds CstF with higher affinity than
L1. Interestingly, again general polyadenylation activity
appears to be altered (but not the absolute levels of
64kD protein) this time decreasing during viral infection.
This then favors the switch from L1 to L3 poly(A) site
use at later stages of the viral life cycle (Mann et al.,
1993).
Conclusions
It is becoming increasingly apparent that there is a sig-
nificant degree of regulated gene expression at the 39
ends of mRNA. As well as the examples discussed
above, a considerable number of genes use alternate
poly(A) signals in the 39 untranslated regions of their
mRNAs. This may result in a further level of regulation,
as although the same protein product will be produced,
different 39 UTRs will be formed which may alter the
stability, translation, or transport of the mRNA. Possibly
the limited examples of this type of gene regulation to
come to light so far reflect more our lack of knowledge
of the complete picture of gene regulation than the ab-
sence of true examples. Indeed the tendency of molecu-
lar geneticists to define mRNA 39 ends only by cDNA
cloning or RT-PCR means that very often the full com-
plexity of alternative polyadenylation will be lost until
more complete sequence data become available.
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